The RSC-BMCS and SCI have joined forces to host an exciting Targeting Protein Degradation event at Cranfield University on 15-16 October 2024.
Charnwood Discovery is happy to announce that we will be exhibiting at the event.
About the RSC-BMCS/SCI Targeting Protein Degradation 4
Targeted Protein Degradation (TPD) is a groundbreaking therapeutic field with rapid growth, projected to reach USD 3,300 million by 2030.
The RCS-BMCS and SCI have designed this event to cover the latest advances in TPD, focusing on PROTACs, molecular glues, and non-PROTAC degraders. Attendees will explore cutting-edge technologies, including computational methods, HT synthesis, and structural biology, attracting experts from academia to the pharmaceutical industry.
Meet Us
Director of Business Development, Europe, Dr Linos Lazarides, Business Development Manger, Europe, Dr Chris Peel and Principal Research Scienist, Dr Patrick McIntyre are at Cranfield University for the event.
They will be available to answer questions about how Charnwood Discovery’s TPD capabilities can help your project hit the next milestone.
If you would like to arrange a meeting with Linos please click the button below. Alternatively you can connect directly with Linos on LinkedIn.
Register for the RSC-BMCS/SCI Targeting Protein Degradation 4
If you would like to learn more about the event and how to register please follow the link below:
- Protein degradation assay development
- Virtual screening
- Medicinal and synthetic chemistry
- ADME / DMPK assays
Find out more from our case study or download our webinar:
